GLA
CVS icon

Good Life Advisors’s CVS Health CVS Stock Holding History

Good Life Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,123
Closed -$212K – 510
2025
Q1 		$212K Sell
3,123
-1,475
-32% -$88.3K 0.01% 462
2024
Q4 		$206K Sell
4,598
-507
-10% -$28.4K 0.02% 459
2024
Q3 		$321K Sell
5,105
-1,077
-17% -$62.8K 0.02% 453
2024
Q2 		$365K Sell
6,182
-19,786
-76% -$1.24M 0.03% 324
2024
Q1 		$2.07M Sell
25,968
-500
-2% -$38.2K 0.18% 103
2023
Q4 		$2.09M Buy
26,468
+22,427
+555% +$1.6M 0.21% 95
2023
Q3 		$282K Buy
4,041
+762
+23% +$54K 0.03% 326
2023
Q2 		$227K Sell
3,279
-1,706
-34% -$121K 0.03% 349
2023
Q1 		$370K Buy
4,985
+308
+7% +$25.8K 0.05% 254
2022
Q4 		$436K Sell
4,677
-19
-0.4% -$1.83K 0.06% 214
2022
Q3 		$448K Buy
4,696
+12
+0.3% +$1.19K 0.07% 202
2022
Q2 		$434K Sell
4,684
-50
-1% -$4.88K 0.06% 208
2022
Q1 		$479K Sell
4,734
-596
-11% -$62.6K 0.06% 209
2021
Q4 		$550K Sell
5,330
-394
-7% -$36.4K 0.07% 195
2021
Q3 		$486K Sell
5,724
-278
-5% -$23.3K 0.07% 202
2021
Q2 		$501K Buy
6,002
+300
+5% +$24.6K 0.1% 157
2021
Q1 		$432K Sell
5,702
-341
-6% -$24.8K 0.09% 173
2020
Q4 		$409K Sell
6,043
-298
-5% -$19.4K 0.1% 150
2020
Q3 		$373K Buy
6,341
+1,022
+19% +$63.6K 0.1% 154
2020
Q2 		$343K Buy
+5,319
New +$335K 0.1% 149
2020
Q1 		– Sell
-3,870
Closed -$288K – 230
2019
Q4 		$288K Sell
3,870
-155
-4% -$10.9K 0.08% 196
2019
Q3 		$251K Buy
4,025
+122
+3% +$7.23K 0.08% 201
2019
Q2 		$213K Buy
+3,903
New +$210K 0.06% 226

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Good Life Advisors's CVS Position: Q2 2025 in Review

Good Life Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,123 shares — an estimated $212K sold.

Good Life Advisors first reported a position in CVS in Q2 2019 and held it in 23 quarters. The position peaked at $2.09M in Q4 2023. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Good Life Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Good Life Advisors sold 3,123 CVS Health shares in Q2 2025, an estimated $212K.
  • Good Life Advisors first reported a position in CVS Health in Q2 2019 and held it in 23 quarters.
  • Good Life Advisors's CVS Health position peaked at $2.09M in Q4 2023.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.